Summary:
Click image to enlarge
Have you been diagnosed with non-infectious uveitis? Are you currently being treated for uveitis with medication?
You may be eligible to participate in a study to evaluate the safety and biologic activity of gevokizumab in treating Non-infectious Uveitis (NIU). The EYEGUARD™ - A study is enrolling subjects with Active Non-Infectious Uveitis and EYEGUARD™ - C is enrolling subjects with Controlled Non-Infectious Uveitis.
Key Study Facts:
- You must be 18 years of age or older
- Subjects will participate for approximately 15 months
- The study will include 20 scheduled study visits
Reasons to join this study:
- Help determine whether the study drug may help people with Non-Infectious Uveitis (NIU)
- Help advance our knowledge of gevokizumab and make important contribution to ophthalmic treatment research
- Receive all study related medical care at no cost (i.e., EKG, X-rays, Physical, Eye Exams etc.)
- Be compensated for your time and travel